Recent Highlights

• Won decision on "issue of first impression" from US Court of Appeals for the First Circuit defining the meaning of "efficiency" for purpose of the fraud-on-the-market theory in federal Rule 10b-5 securities litigation.
• Won dismissals of securities class action and derivative litigation on behalf of medical device maker arising out of FDA approval process.
• Successfully represented early-stage pharmaceutical  company in securities class action litigation arising from co-development relationship with NIH.
• Representation of public high-technology logistics company through accounting restatement, internal investigation and SEC enforcement action, as well as securities class action and derivative litigation.
• Representation of several high technology and biotechnology clients in parallel securities class and derivative litigation, internal investigations and SEC enforcement proceedings
• Successful representation of digital media technology company in connection with merger review before the Antitrust Division of the US Department of Justice and European Commission
• Won dismissal of nationwide federal class action involving on-line enrollment practices of internet membership club
• Representation of board of publicly traded REIT in class litigation arising from going private transaction
• Won "major legal victory" (Boston Globe, 1/ 27/06) following six-week trial on behalf of class of mentally impaired children seeking new treatments under the Medicaid Act
• Obtained dismissals in separate consumer class actions against building materials manufacturer and national car sharing service, respectively
• Secured federal court approval of favorable settlement of nationwide class litigation against internet marketing company over objection of New York Attorney General
• Representation of retail merchant before the FTC, and in multiple related private lawsuits, including successful affirmance of dismissal in appeal to the Massachusetts Supreme Judicial Court, arising from the possible compromise of personal identity and credit card data of customers
• Eighty-five day arbitration of complex cost accounting and fraud matter on behalf of medical device manufacturer
• Successful defense of an investment company in fiduciary duty action involving close corporation through trial, appeal and certiorari to the US Supreme Court